Martins Emeje obtained BPharm with distinction from Ahmadu Bello University, MPharm and Ph.D. from University of Nigeria, where he received the best PhD award and was enlisted as UNN’s “Face of Research.” He established the first nanomedicine center in Nigeria. He was the pioneer head of the intellectual property and technology transfer as well as the technology innovation and support center. Prof. Emeje’s several international fellowships include the prestigious Raman fellowship. He has over 150 primary scientific publications, patents, trademarks, and public opinions in print and electronic media. He has a postgraduate certificate in Project Management from Walden University, Minnesota, as well as a professional teaching certificate and a World Bank certification in Public Procurement.

He is an examiner to universities in Ghana, India and Nigeria. He was an adjunct lecturer at University of Uyo for nine (9) years, during which he developed the postgraduate curriculum for the department of Pharmaceutics. He currently supervises postgraduate students in Universities in Nigeria and abroad. Emeje was Head, NIPCO during which the first indigenous phytomedicine was licensed to a pharmaceutical company.

Emeje is a recipient of several grants including the American Cancer Society grant for the development of Oral morphine solution; $11.6M grant for development of drugs for malaria, tuberculosis and diabetes as well as a 2022 Royal Society grant. His work on herbal formulations resulted in three major registered products in the market. His work in the application of nanotechnology in drug delivery won WHO/ANDI innovation award.

Prof. Emeje was a national chairman of academic pharmacists in Nigeria, a member of WHO Expert Committee, a consultant to WHO on MSMEs and the 2021 winner of the May & Baker Nigeria Plc–sponsored prize for professional service in research and innovation. Prof. Emeje was recently named as the Vice-Chancellor, European University of Nigeria.